|
⚲
|
| Keyboard |
| Scott Kellen | |
|---|---|
| Firm | |
| Address | 301 Carlson Parkway Suite 210 Minneapolis, MN 55305 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Diamedica Therapeutics Inc | 021-552749 | Executive Officer | 30.1 M of 30.1 M |
||
| Diamedica Therapeutics Inc | 021-517673 | Executive Officer | 11.8 M of 11.8 M |
||
| Diamedica Therapeutics Inc | 021-485302 | Executive Officer | 37.5 M of 37.5 M |
||
| Diamedica Therapeutics Inc | 021-479300 | Executive Officer | 0.8 M of 0.8 M |
||
| Diamedica Therapeutics Inc | 021-415804 | Executive Officer | 30.0 M of 30.0 M |
||
| Diamedica Therapeutics Inc | 021-310347 | Executive Officer | 0.2 M of 0.3 M |
||
| Sun Biopharma Inc | 021-307009 | Executive Officer | 0.8 M of 20.0 M |
||
| Sun Biopharma Inc | 021-281891 | Executive Officer | 1.5 M of 5.0 M |
||
| Sun Biopharma Inc | 021-265852 | Executive Officer | 2.0 M of 5.0 M |
||
| KIPS Bay Medical Inc | 021-236938 | Executive Officer | 3.2 M of 3.2 M |
||
| KIPS Bay Medical Inc | 021-167954 | Executive Officer | 0.6 M of 20.6 M |
||